National Screening Committee. Criteria for Appraising The Viability, Effectiveness and Appropriateness of a Screening Programme. London: NSC, 2003. See http://www.library.nhs.uk/screening/ViewResource.aspx?resID=59772 (last checked 30 December 2007)
2.
Robins WhalinTB. To know or not to know: a review of behaviour and suicidal ideation in preclinical Huntington's disease. Patient Educ Couns2007;65:279–87
3.
TaylorSD. Predictive genetic test decisions for Huntington's disease: context, appraisal and new moral imperatives. Soc Sci Med2004;58:137–49
4.
ReisC, HeislerM, AmowitzLL, Discriminatory attitudes and practices by health workers toward patients with HIV/AIDS in Nigeria. PLoS Med2005;2:e246. Epub 19 July 2005
5.
LaphamEV, KozmaC, WeissJO. Genetic discrimination: perspectives of consumers. Science1996;274:621–4
6.
KayeCICommittee on GeneticsAccursoF, La FranchiS, Introduction to the newborn screening fact sheets. Paediatrics2006;118:1304–12
7.
GostinLO. HIV testing in health care settings: Public Health and Civil Liberties in conflict. JAMA2006;296:2023–5
8.
RennieS, BehetsF. Desperately seeking targets: the ethics of routine HIV testing in low-income countries. Bull World Health Organ2006;84:52–7
9.
SlowtherA. The concept of autonomy and its interpretation in health care. Clinical Ethics2007;2:173–5
10.
AtkinsonK, ZuckermanB, SharfsteinJM, LevinD, BlattRJ, KohHK. A public health response to emerging technology: expansion of the Massachusetts newborn screening program. Public Health Rep2001;116:122–3
11.
FosterP, AndersonCM. Reaching targets in the national cervical screening programme: are current practices unethical?J Med Ethics1998;24:151–7
12.
General Medical Council. Seeking Patients' Consent: The Ethical Considerations. London: GMC, 1998: para 34
13.
JepsonRG, HewisonJ, ThompsonA, WellerD. How should we measure informed choice? The case of cancer screening. J Med Ethics2005;31:192–6
14.
TassickerR, SavulescuJ, SkeneL, MarshallP, FitzgeraldL, DelatyckiMB. Prenatal diagnosis requests for Huntington's disease when the father is at risk and does not want to know his genetic status: clinical, legal, and ethical viewpoints. BMJ2003;326:331–3
15.
ParkerM, LucassenA. Concern for families and individuals in clinical genetics. J Med Ethics2003;29:70–3
16.
NewsonAJ, HumphriesSE. Cascade testing in familial hypercholesterolaemia: how should family members be contacted?Eur J Hum Genet2005;13:401–8
17.
SlowtherA. Sharing information in health care: the nature and limits of confidentiality. Clinical Ethics2006;1:82–4
18.
BorryP, FrynsJP, SchotsmansP, DierickxK. Carrier testing in minors: a systematic review of guidelines and position papers. Eur J Hum Genet2006;14:133–8
19.
Nuffield Council on Bioethics. Genetic Screening Ethical Issues. London: Nuffield Council, 1993(2006 supplement). See http://www.nuffieldbioethics.org/go/ourwork/geneticscreening/introduction
20.
UK National Screening Committee. See http://www.nsc.nhs.uk/uk_nsc/uk_nsc_ind.htm
